(Q28111976)

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus latency in the nervous system--a new model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Detection of HSV-1 genome in central nervous system of latently infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Latent herpes simplex virus type 1 transcription in human trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Characterization of Herpes Simplex Virus Type 2 Latency-Associated Transcription in Human Sacral Ganglia and in Cell Culture

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Configuration of latent varicella-zoster virus DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella-zoster virus gene expression in latently infected and explanted human ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella-zoster virus latency in human ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella-zoster virus gene 66 transcription and translation in latently infected human Ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

A molecular and cellular model to explain the differences in reactivation from latency by herpes simplex and varicella-zoster viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Comparative biology of latent varicella-zoster virus and herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus type 2 in the United States, 1976 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Subclinical reactivation of herpes simplex virus type 1 in the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus infections in neonates and early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

1 reference

7 January 2021

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella zoster virus vaccination policies and surveillance strategies in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. The Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

An explanation for the localization of herpes simplex encephalitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex type 1 DNA in human brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Olfactory mucosa in herpes simplex encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

DNA Restriction-Enzyme Analysis of Herpes Simplex Virus Isolates Obtained from Patients with Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Viral encephalitis: causes, differential diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus encephalitis in human UNC-93B deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Molecular anatomy of viral persistence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus turns off the TAP to evade host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

A viral inhibitor of peptide transporters for antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Acute Viral Encephalitis in Adults?a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Computed tomography of the head before lumbar puncture in adults with suspected meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

To biopsy or not to biopsy in suspected herpes simplex encephalitis: a quantitative analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Computed tomography and EEG in herpes simplex encephalitis. Their value in diagnosis and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Vidarabine versus acyclovir therapy in herpes simplex encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Relapse of herpes simplex encephalitis after conventional acyclovir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus infection of the fetus and newborn

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Neonatal herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Twenty-eight years of benign recurring Mollaret meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Benign aseptic (Mollaret's) meningitis after genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Mollaret's meningitis associated with herpes simplex type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Zoster in the elderly: clinical, immunologic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Neurologic complications of the reactivation of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Immune responses to varicella-zoster in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Antibody Responses to Varicella-Zoster Virus and the Role of Antibody in Host Defense

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Preherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Zoster sine herpete, a clinical variant

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes zoster encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella-Zoster infection in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Clinical practice. Herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Risk of Cancer after Herpes Zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Dermal transmission of virus as a cause of shingles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

An Outbreak of Varicella-Zoster Virus Infection Among Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes Zoster in African Patients: An Early Manifestation of HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

RISK OF AIDS AFTER HERPES ZOSTER

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, [...]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Landry-Guillain-Barre syndrome after chicken pox

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Polyneuritis and herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Reye's syndrome: hold the obituary.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Reye syndrome--insights on causation and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

The disappearance of Reye's syndrome--a public health triumph

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Persistent Multiple Pulmonary Nodules in a Nonimmunocompromised Woman after Varicella-Related Myelitis Treated with Acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Spinal cord involvement in uncomplicated herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Zoster myelitis: improvement with antiviral therapy in two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Parainfectious optic neuritis. Report and review following varicella

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Isolated bilateral anterior optic neuritis following chickenpox in an immunocompetent adult

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Unilateral retrobulbar optic neuritis due to varicella zoster virus in a patient with AIDS: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Viral diagnosis of neurological infection by RT multiplex PCR: a search for entero- and herpesviruses in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Acute central nervous system complications in varicella zoster virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella zoster virus encephalitis in a previously healthy five-year-old child with herpes zoster ophthalmicus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella-zoster virus: atypical presentations and unusual complications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

The patterns of varicella zoster virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Acute childhood hemiplegia associated with chickenpox

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Hemispheric infarction after herpes zoster ophthalmicus: computed tomography and angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella zoster virus-associated focal vasculitis without herpes zoster: recovery after treatment with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

The vasculopathy of varicella-zoster virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Cerebrovascular disease and varicella in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Chickenpox and stroke in childhood: a study of frequency and causation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Segmental zoster paresis--a disease profile

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Cervical herpes zoster and diaphragmatic paralysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Diaphragmatic paralysis following cervical herpes zoster.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes zoster with dysfunction of bladder and anus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Motor involvement in acute herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Postherpetic neuralgia--pathogenesis, treatment, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Neuropathic pain and injured nerve: central mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Understanding pain in herpes zoster: an essential for optimizing treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Prevention and treatment of postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Topical lidocaine gel relieves postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Can vaccinating older adults against varicella zoster virus prevent herpes zoster and postherpetic neuralgia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Intractable seizure disorder associated with chronic herpes infection. HSV1 detection in tissue by the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Infection and the etiology and pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

"Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes simplex virus type 1 in brain and risk of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Brain lipoprotein metabolism and its relation to neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Herpes-simplex virus as a cause of Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Highly variable distribution of HSV-1-specific DNA in human geniculate, vestibular and spiral ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Bell's palsy and herpes viruses: to (acyclo)vir or not to (acyclo)vir?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970267-3

7 January 2021

10.1016/S1474-4422(07)70267-3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1427347

1427347

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference